Gordon Christopher R

4.0

4.0

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Cerevel Therapeutics Holdings Inc (CERE)

Transaction date 16 Oct 2023

Purchase

Price

92.31

Quantity 58,199 +41.4%

Value US$2,578,924

Comments Filing

Cerevel Therapeutics Holdings Inc (CERE)

Transaction date 9 Nov 2020

Purchase

Price

263.90

Quantity 3,396 -41.7%

Value US$3,905,215

Comments Filing

Cerevel Therapeutics Holdings Inc (CERE)

Transaction date 27 Oct 2020

Purchase

Price

298.22

Quantity 75,976 -14.1%

Value US$946,713

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2023-10-18	2023-10-16	Cerevel Therapeutics Holdings Inc (CERE)	B Purchase	58,199 +41.4% 92.31 US$2,578,924	58,199 +41.4%	92.31	US$2,578,924
2020-11-12	2020-11-09	Cerevel Therapeutics Holdings Inc (CERE)	B Purchase	3,396 -41.7% 263.90 US$3,905,215	3,396 -41.7%	263.90	US$3,905,215
2020-10-29	2020-10-27	Cerevel Therapeutics Holdings Inc (CERE)	B Purchase	75,976 -14.1% 298.22 US$946,713	75,976 -14.1%	298.22	US$946,713